Trial designs and outcomes in dementia therapeutic research
General Material Designation
[Book]
First Statement of Responsibility
edited by Kenneth Rockwood, Serge Gauthier.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
London ; New York
Name of Publisher, Distributor, etc.
Taylor & Francis
Date of Publication, Distribution, etc.
2006
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xii, 300 p.) : ill., fichiers PDF
GENERAL NOTES
Text of Note
Titre de l'écran-titre (visionné le 8 mars 2010).;In Informa Healthcare.
CONTENTS NOTE
Text of Note
Introduction. The History of Therapeutic Trials in Dementia. Therapeutic Strategies. Treatment Hypotheses. Clinical Trial Designs & Selection of Primary vs.Secondary Endpoints. Qualitative Analyses of Disease Treatment Effects. Inclusion and Exclusion Criteria. Global Outcomes. Cognitive Outcomes. Functional Outcomes. Behavioral Outcomes In Trials Of Cognitive Agents. Quality of Life Outcomes. Caregiver Burden Outcomes. Neuroimaging Outcomes. Additional Lessons From Trials in Vascular Dementia. Additional Lessons From Trials In Dementia With Lewy Bodies. Lessons From Trials To Prevent Dementia. Herbal Treatments for Dementia. Lessons from Trials of Psychoactive Compounds in Alzheimer's Disease. Lessons from Non-Pharmacologic and Psychosocial Interventions for Patients with Dementia. Lessons from Psychosocial Interventions Aimed at Caregivers of People with Dementia. Lessons from Trials in Mild Cognitive Impairment. Pharmacoeconomic Outcomes. Executive Dysfunction in Dementia. Ethical Issues. Conclusions.